Article: When Orphan Drugs Make All the Difference

By World Courier |
Insights Home
Orphan drugs are growing in importance worldwide. However, bringing an orphan drug to market unique challenges and considerations. Overcoming these challenges requires the cooperation of clinical trial investigators, drug manufacturers, local and national governments and more.
Topics:
Clinical Trial Logistics

Related Content

World Courier

Webinar on-demand: Lessons for the Commercial Supply Chain Taken From the Clinical Trials Model

A portrait of Christopher Engel.
Christopher Engel
June 2018

World Courier

Infographic: Direct-to-Patient Clinical Trials

Inverted color AmerisourceBergen icon
World Courier
December 2017

Learn about the 12 steps to mobilize for success in direct-to-patient clinical trials

World Courier

Video: What lessons can the commercial supply chain take from the clinical supplies model?

Portrait of Sam Herbert
Sam Herbert
August 2017

World Courier uses our expertise and experience to deal with custom requirements before the commercial supply chain has to think about them. Hear from Sam Herbert, President of World Courier as he discusses the lessons we have learnt.